Try our Advanced Search for more refined results
Life Sciences - August, 2020
388 articles
- Trump's New Nursing-Home Tests Fuel 'Herd Immunity' Debate
- Gannett Escapes $500M COVID-19 Story Libel Suit, For Now
- Bio-Rad Gets 10X Genomics' Antitrust Claims Trimmed
- DOD Investigating Moderna's Vaccine Patents
- Neb. Sheriff Sues To Block State's Medical Pot Ballot Measure
- AbbVie Points 3rd Circ. To School Board Ruling In FTC Case
- BigLaw Cannot Reap Diversity Rewards Without Inclusion
- How COVID-19 May Forever Alter Work Life For Disabled Attys
- Ideas For Closing BigLaw's Diversity Gap
- How Law Firms Can Hire And Retain More Black Attorneys
- Diversity Snapshot: As Told By Black Law Firm Leaders
- These Law Firms Have The Most Diverse Equity Partnerships
- BigLaw Needs More Underrepresented Attorneys As Leaders
- Advancing Racial Justice In The Legal Industry And Beyond
- In Their Own Words: Being Black In BigLaw
- Boehringer Hits Sun Pharma With Suit Over Diabetes Generic
- Perrigo Faces Patent Suit Over Bausch's Psoriasis Lotion
- Judges Mull Whether Word 'Random' Kills Bayer Patent Win
- Ex-Indivior Exec Inks Plea Deal In Suboxone Opioid Case
- Gov't Contracts Of The Month: Vaccines, Space, AI Research
- Withers Continues To Grow Arbitration Practice In Singapore
- Nestle To Buy $2.6B Peanut Allergy Drug Developer
- HHS Lab Test Rule's Likely Impact During And After COVID-19
- Excess Insurer Owes Pfizer Coverage For Securities MDL
- Biopharma Co. Trevena Must Face Investors' Stock-Drop Suit
- States Urge High Court To Revive FDA's Abortion Pill Rules
- Vi-Jon Wants Hand Sanitizer False Ad Suit Wiped Out
- Law360's Diversity Snapshot: What You Need To Know
- One Year In, Mansfield Rule Is Boosting In-House Diversity
- Law360 Diversity Snapshot: How Does Your Firm Measure Up?
- Why 2020 Could Be A Pivotal Year For Diversity At Firms
- Diversity Work Doesn't Have To Be Reserved For Partners
- Fed. Circ. Won't Revive Pfizer's Fungus Treatment Patents
- Theranos Ex-COO Wants Latest Indictments Dismissed
- Biz 'Relies On Arb Clauses,' Justices Told In Dental Row
- UVA Researcher From China Stole Trade Secrets, Feds Say
- Activists Say Moderna Hid Gov't Support For Vaccine Patents
- Biotech Co. Says Ex-Worker Violated Trade Secrets Deal
- Pa. Sales Rep Says He Was Fired Over Medical Marijuana Use
- FCC Rejects Challenge To ViSalus Robocall Waiver
- Nebraska Medical Pot Proposal Beats '11th Hour' Challenge
- Judge Won't Rethink Sanctioning Atty, Co. In Shire IP Dispute
- Feds Sign $760M Deal For Abbott's Rapid COVID-19 Tests
- Brandt Urges Pause In BIPA Suit Until Appellate Rulings
- Sens. Want Nursing Home Probe Over Hydroxychloroquine
- IP Atty Gets Damages Slashed In Fight With Drug Pump Cos.
- SF Says Drug Cos. Are Liable For City Damage In Opioid Case
- Hologic Gets NovaSure Patent Judgment Bumped Up To $7M
- Seattle Bashes Bayer's $650M PCB Deals As A 'Pittance'
- Taxation With Representation: Paul Weiss, Simpson, Skadden
- IP Hires: Haynes & Boone, Barnes & Thornburg, White & Case
- Cannabis Cos. Can't Ignore TCPA Compliance
- Lone Star Laterals: Munsch Hardt, King & Spalding
- B. Braun Medical Hit With ERISA Suit Over 401(k) Costs
- Hagens Berman Must Face Legal Malpractice Suit In Pa.
- Bayer's $10B Roundup Deal Teeters As Victims' Attys Cry Foul
- Fla. Regulator Clears Way For Medical Marijuana Edibles
- Melinta Rips Investor Challenge To Its Confirmed Ch. 11 Plan
- Nature's Way Ginkgo Pill Buyers Reach $3.4M False Ad Deal
- Medical Pot Exec Shared Trade Secrets With Rivals, Suit Says
- Shuttered Abbott Unit Beats Whistleblower's FCA Suit
- No Constitutional Right To Pot Licenses, Fla. Tells 11th Circ.
- Lab Accused Of Sending Junk Faxes For Its COVID-19 Testing
- Baxalta's IP Suit Over Genentech Blood Drug Gets New Life
- Pa. Avoiding Discovery In Price-Fixing Case, Drugmakers Say
- 4 Opportunities For Mediators To Settle Big-Dollar Cases
- Farmers Group Sues Monsanto To Get Roundup Off Shelves
- Another Pradaxa Labeling Suit Tossed In Connecticut
- COVID-19 Vaccine May Pose New Challenges For Employers
- Lantus Buyers Demand Info On More Sanofi Injector Patents
- Justices Told False Ad Cases Don't Require 'Actual Injury'
- Amgen Blasts Sandoz's En Banc Bid In Enbrel Patent Fight
- Pharma Co. Otsuka Buys Bankrupt Smart-Pill Maker For $15M
- Pharmacies Torch 'Unprecedented' Ruling On Opioid Duties
- Revive Abortion Drug Rules Despite Virus, FDA Tells Justices
- 1st Circ. Affirms New Lead Plaintiff Can't Save Biotech Suit
- Minn. Pushes Back On Drug Cos.' Bid To Kill Insulin RICO Suit
- The Growing Challenges To Drug Cos.' Preemption Defense
- Fenwick Helps Cancer Biotech Freenome Raise $270M
- Okla. Pot Regulators Say Testing Lab Falsified Results
- Remote Proceedings Bring New Wrinkles For Court Records
- Teva Is 7th Drug Co. Charged In DOJ Price-Fixing Probe
- John Ashcroft Joins Team Fighting J&J To Keep $2B Talc Win
- Two More Settlements OK'd In Nevada Pot Licensing Snafu
- Ex-Pharma CEO Charged With Inside Trading Over Teva Deal
- Ex-DOJ Civil Chief, Back In BigLaw, Dishes On Hot FCA Topics
- Invisalign Maker Says Qualcomm Ruling Supports Escape Bid
- Goodwin Nabs Ex-HHS Atty From Bass Berry
- Senate Bill Would Give FDA Authority To Recall Drugs
- Dealing With Prior DOJ Health Investigations During COVID-19
- Latham, Simpson Shape $320M Cryogenic Services Merger
- Cross-Selling Strategies For Law Firms During Pandemic
- Coronavirus Regulations: A State-By-State Week In Review
- Baxter Wants Investor Suit Over Forex Accounting Tossed
- Del. Croda Plant Hit With Toxic Chemical Release Suit
- FCPA Enforcement, Compliance Trends During The Pandemic
- Paul Hastings Welcomes Back Partner After In-House Stint
- Court Looks To Streamline Dispute Between IQVIA And Veeva
- Biotech Co. Lied About COVID-19 Vaccine, Investors Say
- Dr. Reddy's Can Add Antitrust Allegations In Suboxone Row
- Gilead Says Law Firm's Ads Misrepresent HIV Drug Suit
- Regeneron Says Feds' Kickback Suit 'Defies Common Sense'
- PTAB Upholds Entirety Of 3 Narcan Patents
- Sun Pharma Unit Pays $21M To End Whistleblower Suit
- Colgate Retirees Win $300M Suit Over Benefit Calculation
- Cannabis Co. Attys Can't Practice In Okla., Shareholders Say
- Ariz. Schools Accuse E-Cig Cos. Of Deceptive Marketing
- Zetia Buyers Granted Cert. Despite Small Class Size
- Weil, Simpson Weld Medical Device Deal Worth Up To $825M
- Chancery Keeps AmerisourceBergen Drug Scheme Suit Alive
- Atty Media Interview Lessons From Trump's Axios Appearance
- 7th Circ. FCA Dismissal Ruling May Have Unintended Effects
- EPA Approves Long-Lasting Coronavirus Disinfectant In Texas
- 2 Firms Help Blackstone Strike $2.3B Deal For Takeda Unit
- SEC Says There's 'No Dispute' Biotech Brass Broke Law
- Drug Cos. Blocking 340B Meds Amid Pandemic, Hospitals Say
- AmerisourceBergen Board Looks To Ax Opioid Derivative Suit
- Mintz Picks Up Partner From Boies Schiller
- Ferring Gets Rival's Patents Scrapped In Zoom Trial Win
- 7th Circ. Told Class Objector Side Deals Ruling Creates Split
- Stryker Corp. Scores Trial Win In XL Insurance Coverage Suit
- Pharma Giants Tee Up Biologics Innovation Fight At Fed. Circ.
- COVID-19 IP Catch-Up: Hatch-Waxman, Vaccine Patents
- Medical Pot Co. Hires Ex-Vitamin Shoppe Atty To Be New GC
- US Should Not Confiscate Gilead's Remdesivir Patent
- Dental Distributor Says Antitrust Fight Must Be Arbitrated
- Ariz. Justices OK Measure To Legalize, Tax Pot For Nov. Ballot
- Berger Montague Drops Bankrupt Client In Lipitor Case
- Taxation With Representation: Cravath, Sullivan, Hogan
- Why Remote Depositions Are Likely Here To Stay
- Alcon Claims Lens.com Led It On 'Antitrust Wild Goose Chase'
- How USPTO Examiner Type Affects Patents: Part 4
- ITC Will Explore Supply Chain Issues For COVID-19 Goods
- Justices Told Fed. Circ. Wrongly OKs PTAB With New Findings
- DEA Proposes Rule For Regulating Hemp-Derived CBD
- 9th Circ. Backs Doctor Aide's Opioid Distribution Conviction
- Pharmacy Board Asks 6th Circ. To Block Opioid Rx Info
- Shkreli's Prison Comms Get Partial Protection From FTC
- 'Artful Pleading' Can't Save Surescripts Antitrust Suit
- 3rd Circ. Upholds Liberty's Win In Pharmacy's Painkiller Suit
- Womble Bond Nabs Ex-Buchanan Ingersoll Patent Litigator
- Hatch-Waxman Complaints Down Sharply During Pandemic
- Vitamin Retailer GNC Cleared To Solicit Votes On Ch. 11 Plan
- 7 Keys To Drafting Effective Legal Briefs
- Consultant Says Express Scripts 'Fabricating' Subpoena Fight
- Bayer Pays $1.6B To Settle Suits Over Essure Contraceptive
- Legend In Law: McKesson's Lori Schechter
- Fed. Circ. Revives Fee Bid In Gardasil Vaccine Act Case
- 4 Firms Vie To Lead Endo Investor Suit Over Opioid Crisis
- McKesson Gets FCA Suit Over Opioids Tossed, For Now
- 9th Circ. Denies DEA Bid To Dismiss Pot Rescheduling Case
- CVS Unit To Pay $4.5M To Settle Workers' Wage Suit
- Weighing The Virtual Courtroom Option In Civil Cases
- ITC Greenlights New Duties On Plastic From S. Korea, Oman
- Pair Of Life Science Cos. Raise Combined $247M In IPOs
- Real Estate Rumors: Bristol-Myers, WeWork, Kaizen
- Dow Dropped From Suit Linking Pesticides To Man's Cancer
- Actavis Inks Settlement In ADHD Drug Antitrust Suit
- Mylan Launches MS Drug Generic Amid Biogen Patent Fight
- Boies Schiller Owns Up To 'Mistake' With Opioid Suit Filing
- A USPTO Examination Policy Change You May Have Missed
- 7th Circ. Ruling Should Deter Class Objector Side Deals
- Cravath, Latham Steer J&J's $6.5B Momenta Buy
- J&J Asks South Carolina Justices To Split 2-Plaintiff Talc Trial
- Vivus Says Ch. 11 Plan Should Be OK'd Despite Opposition
- Mallinckrodt Must Face Infant Drug Pricing Claims
- 7th Circ. FCA Ruling Deepens Circuit Split On DOJ Dismissals
- Patients Want 2nd Circ. To Revive Pfizer Lipitor Suit
- NJ High Court Lets Pfizer Arbitrate Flight Attendant's Bias Suit
- 'Pharma Bro' Shkreli Suggests FTC Privacy Violation
- 5 Considerations For Enhancing SEC Disclosures Amid Crisis
- Surgeon, Distributor Cop To Kickbacks In Medical Fraud Case
- Attys Shouldn't Overlook Obligations To Potential Clients
- ICE Contractor Raps Whistleblower Fraud Report As Too Late
- Wash. Pot Co. Says Okla. Residency Rules Unconstitutional
- Endo Fights Class Cert. In Investors' Drug Price-Fixing Suit
- Lessons From Asbestos Can Help Resolve Opioid Liabilities
- 8 Firms Bid To Lead Stock Suit Over Revoked COVID-19 Test
- Purdue And Sacklers Caused $2.16T In Damage, NY Says
- Coronavirus Regulations: A State-By-State Week In Review
- Boehringer Strikes Deal To End DOL Pay Bias Probe
- How Pa. Cost-Of-Performance Decision May Affect Taxpayers
- Teva Paid $300M Kickbacks Through Copay Groups, Feds Say
- Cochlear To Pay $75M More If $268M Hearing IP Loss Stands
- Noncompete Considerations As Businesses Reopen, Rehire
- Novartis' MS Drug Patent Upheld And Generic Ruled Infringing
- Ex-NFL Player Takes Pot Legalization Fight To High Court
- Ex-DEA Agent Said Parts Of Opioid Report Taken From NY Suit
- Allergan Wins Bid To ID Breast Implant Patients In MDL
- DC Circ. Won't Revisit Eagle's Orphan Drug Win Against FDA
- Glumetza Buyers Get Cert. In Suit Over 800% Price Jump
- Zetia Buyers Win Recommendation For Class Cert.
- Lexicon Pharma Ditches Investor Suit Over Diabetes Drug
- Inflammatory Disease Biotech Kymera Launches $125M IPO
- CBD Co. Says Texas Pot Lobby Defamed It With Phony Report
- Speaker Program Limits Are Specific To Novartis Settlement
- Weil, Cooley Guide $3.7B Sanofi, Principia Biopharma Deal
- Medical Co. Sues Over Counterfeit Forehead Thermometers
- Strategies For Associates Seeking Jobs Amid Hiring Slump
- Biopharm Co. Leaders Accused Of 'Grossly Excessive' Pay
- IRS Urges 10th Circ. To Toss Pot Cos.' Tax Summons Fight
- Ex-Client Fights Hagens Berman Bid To End Malpractice Suit
- Merck Loses Appeal In NJ Zoning Change Challenge
- Can Big Damages Awards Affect Patent Valuation Dynamics?
- 1st COVID-19 Vaccine Patent Granted, Chinese Media Says
- ViSalus Can't Get $925M Robocall Damages Award Cut Down
- Ex-FDA Head Says He Didn't Ask NY Docs About Opioid Rx's
- McKesson's $178M Vaccine Deal Brings CDC Off The Bench
- Ex-Insys Sales Rep Evades Prison Over Opioid Bribe Ploy
- 9th Circ. Upholds $3.6M Award In Bard Filter Bellwether
- 3 Ways Life Sciences Cos. Can Protect Trade Secrets
- Constitutional Right To Prescribe Pot Hazy, 6th Circ. Says
- Cannabis Corruption Cases Ramp Up With FBI Scrutiny
- Mallinckrodt Must Face Antitrust Claims Over Seizure Drug
- 3M Inks Deal To End Mask Suit Against Amazon Vendor
- COVID-19 IP Catch-Up: All Eyes On Texas
- Belcher Tells Fed. Circ. Inequitable Conduct Order Implausible
- Fitness Co. Can't Sue Google Over Video Removal
- COVID-19 Vaccine Maker, Software Co. IPOs Raise $618M
- Safeguards Against Legal Malpractice Liability As Claims Rise
- UK Litigation Roundup: Here's What You Missed In London
- 4th Circ. Won't Pause Block On FDA Abortion Pill Limits
- 3 Key Developments As COVID-19 Testing Czar Jabs Critics
- Customedia Tells Justices Fed. Circ. Arthrex Denial Is 'Unjust'
- Chancery Makes Juul Investor Seek Docs In Del., Not Calif.
- House Panel Seeks Answers On Virus Vaccine Campaign
- Irked Judge Says Boies Schiller Flouted Opioid MDL Order
- 6th Circ. Reinstates J&J Pelvic Mesh Suit
- McKesson, Cardinal Get Green Light For Opioid Bench Trial
- Juul Loses Bid To Arbitrate Canvassers' Wage Class Action
- Canadian Co. Says Hemp Dispute Can't Jump Between Courts
- Ill. Doctors Can't Dodge Sanctions Over Unserved Patent Suit
- Coronavirus Q&A: Akin Gump Partners On Virus Relief Probes
- FTC Says Shkreli's Prison Calls With Attorneys Not Privileged
- Proposed Vaccine Injury Rule Raises COVID-19 Concerns
- McDermott Nabs Pair Of IP Pros From Polsinelli
- AbbVie Calif. Settlement Guides Nurse Education Compliance
- Sorrento Investors Fight To Lead COVID-19 'Cure' Suit
- Cos. Must Heed FDA Warnings On Hand Sanitizers
- 3 Ways Law Firms Can Guard Diversity Gains During Crisis
- Qiagen Investors Shun Thermo Fisher's $12.5B Offer
- Kilpatrick Lures Texas Patent Pro From Vinson & Elkins
- Pharmacy Pays $3.5M To Settle DOJ Medicare Kickback Probe
- J&J Asks Mo. High Court To Overturn $2.1B Talc Ruling
- Pfizer Gets PTAB To Wipe Out Rest Of Sanofi's Lantus Patent
- SmileDirectClub Points To Ga. Dental Board Win In Ala. Appeal
- Nestle Hit With IP Suit Over Doc's Swallowing Test
- Resellers Say Drug Makers Erred In MDL Bellwether Claim
- 3 Firms Shape $384M Cancer Biopharma Co. Take-Private Deal
- Colgate Fights Retirees' Quick Win Bid In ERISA Class Action
- SoftBank-Backed Fortress SPAC Leads 2 IPOs Totaling $405M
- Jones Day Partner Up For Calif. Seat Lists Nearly $2M Assets
- BGI Genomics Can Develop DNA Tech During Patent Appeal
- Money Moves: Alston & Bird, Norton Rose, Saxton & Stump
- Opioid Hearings In NY AG's Suit Will Be Made Public
- How Orange Book Listings Affect Patent Density, Exclusivity
- J&J, Bayer, Teva Sued Over Eye Damage From Cyst Meds
- What I Learned As A Virtual Summer Associate
- Rising Star: Steptoe & Johnson's Vishal Gupta
- Sustainable Food Progress May Close Global Regulatory Gap
- Pandemic Sends Cannabis Sprout Cultivator Into Ch. 11
- Moderna Inks $1.5B Deal For COVID-19 Vaccine Candidate
- Fed. Circ. Urged To Undo Amgen's Win Over Cancer Drug IP
- Drugmakers Say Resellers Trying To Duck Bellwether Status
- W.Va. Doctor Illegally Prescribed Opioids, Jury Finds
- New Latham Partner Says It's 'Back To Biz' For Emerging Cos.
- Fluoride Risk Question Headed Back To EPA After Trial
- Mylan Asks Fed. Circ. To Undo PTAB Loss In Tecfidera Fight
- 'Questionable' Advice Lets Oxygen Mask Co. Dodge Contempt
- FDA Should Follow FTC For Influencer Health Post Rules
- Cooley Helps Atomwise Nab $123M For Drug Discovery Tech
- Tenn. DAs' Sackler Claims Still Blocked By Purdue Ch. 11
- Coronavirus Regulations: A State-By-State Week In Review
- Ex-Theranos CEO's Criminal Trial Moved To 2021 Due To Virus
- FDA Pressed To Take E-Cigs Off Market During Pandemic
- Linklaters, Goodwin Steer Bayer's $425M Women's Health Bet
- Rising Star: Skadden's Laura Knoll
- Lesser-Known Litigation Funding Best Practices For Attorneys
- SEC Reaches Settlement With Accused COVID-19 Fraudster
- MEI Pharma Lied About Cancer Drug's Potential, Investor Says
- Lawyer Says Thalidomide Client's Claims Are Years Late
- Botox Maker's IP Win 'Threatens Public Health,' ITC Told
- Calif. Judge Finds Del. Law Shields Directors In Ch. 11 Suit
- Green Thumb Can't Halt Arkansas Rival's Medical Pot License
- Ariz. Judge Tosses Challenge To Legal Pot Ballot Initiative
- Allergan Says Breast Implant MDL Claims Are Preempted
- Opioid Cos. Say NY Trial Shouldn't Be Livestreamed
- USD Law Dean Joins Perkins Coie's Emerging Cos. Group
- ADA Protects Lawyers With Disabilities, But We Must Do More
- Rising Star: Ropes & Gray's Zachary Blume
- Coronavirus Vaccine Contender CureVac Launches $200M IPO
- 9th Circ. Won't Rethink Rejected PetIQ Merger Challenge
- Kodak's $765M Loan Put On Hold Amid Stock Trading Scrutiny
- Legal Deserts Threaten Justice In Rural America
- Del. Judge Nixes Equity Panel In Biopharma Vivus' Ch. 11
- Trump's US-Made Drug Decree Sows Uncertainty In Industry
- Illumina Still Can't Get Injunction On Top Of $27M Patent Win
- COVID-19 IP Catch-Up: Remdesivir Drama & Jury Trial Regret
- Nev. Pot Regulators Sign Off On Settlement In License Fight
- JPML Consolidates Profemur Hip Implant Suits In Ark.
- Ex-NFL Players' Painkiller Suit Revived By 9th Circ.
- NAACP Wants Seat At Table In Purdue Bankruptcy Case
- HHS' $646M Virus Respirator Deal Faces Mounting Scrutiny
- Surgical Device Co. Says J&J Shouldn't Have Seized Products
- Tracking Arthrex At The Supreme Court
- K&L Gates Nabs Ex-Squire Patton Boggs Patent Pro In SF
- Coronavirus Q&A: Hogan Lovells' Medical Devices Director
- Gilead Can't Sit On Remdesivir Alternative, Activists Say
- Mich. Pot Regulator Recalls Joints After Worker Licked One
- Investors Pour $55M Into Diabetes-Focused Biotech Fractyl
- DLA Piper Adds Former US Rep. As Life Sciences Adviser
- Rising Star: Jones Day's Sarah A. Geers
- MD Who Gave Patient Info To Drug Rep Can't Nix Conviction
- Bayer, Merck Can't Be Pulled Back In Leg Amputation Suit
- Most Courts Follow 1st Circ. Generic-Delay Ruling's Standard
- White House Seeks To 'Onshore' Key Drug Manufacturing
- DEA Beats Discovery Subpoenas In Opioid MDL Bellwether
- Holistic Texas Biz Offered Bogus COVID-19 Tests, Feds Say
- 7th Circ. Says Class Objectors Must Repay Side Deals
- Judge Halts Calif. Pot Delivery Trial With Last-Minute Question
- Hemp Cos. Challenge Texas' Smokable Product Sale Ban
- 7th Circ. Says Chemist Can't Pin Firing On Caring For Grandpa
- AbbVie Inks $24M Deal With Calif. Regulators In Humira Case
- OECD To Consider Exemptions For New Tax System In Report
- Calif. County Can't Use Zoning To Seize Pot Plants, Court Says
- Retailers Face Uphill Fight For Cert. In Glumetza Price-Fix Suit
- Pharmacies Can't Dodge Ohio Opioid MDL's 2021 Bellwether
- Mass. Pot Shop Fined For Selling Faulty Vape Cartridges
- Analyzing Upward And Downward Trends In Legal Tech
- Paul Hastings Nabs Sidley Pair For FDA Regulatory Group
- Biogen Strikes Up To $2B Deal For Parkinson's Drug Collab
- What You Missed At PTAB: Contours Of IPR Institution Denial
- Bristol-Myers, Pfizer Win Fight Over Eliquis Patents
- Alleged Counterfeiter Seeks To Nix J&J Atty's Declarations
- Vivus Eases Equity Committee 'Death Trap' In Ch. 11 Plan
- DOJ Says Pot Study Fight Doesn't Belong In 9th Circ.
- Boehringer Dodges Sanctions In Florida Pradaxa Disputes
- Immunex Faces Skeptical Fed. Circ. In Antibody Patent Fight
- Colgate Retirees Want Judge's Final Word For ERISA Appeal
- Cannabis Operator TerrAscend Names New Top Lawyer
- Pa. Treasurer Slams Gilead's Coronavirus Treatment Pricing
- Lessons From Novartis' $678M Speaker Program Settlement
- EpiPen Buyers Lose Bid For Class Status In ERISA Suit
- Rite Aid Names Former Epstein Becker, LifePoint Atty As GC
- High Court Should Review Arthrex Case
- ABA's New Guidance On Litigation Funding Misses The Mark
- NJ Court Revives Suits Alleging J&J Talc Caused Cancer
- Cos. Should Track Microplastic Research And Regulations
- J&J Strikes $1B COVID-19 Vaccine Agreement With The Feds
- Adventist Rips Dismissal Bid In $57M PPE 'Conspiracy' Case
- 9th Circ. Rejects DOJ's Quick Appeal In Bid To End FCA Suit
- Bankrupt Whistleblower Can Sue Medical Co. In Kickback Row
- SEC Said To Be Probing Kodak Stock Spike After Gov't Loan
- More Finance Tools Go Hand-In-Hand With Larger SPAC Deals
- Ex-Rep. Collins Wants Sentence Delayed 3rd Time Over Virus
- 7th Circ. Told Chubb Unit Must Cover Lab's $3.3M TCPA Deal
- NY Doc Must Face Consumer Fraud Claim In Med Mal Suit
- Free COVID-19 Tests Are Not Kickbacks, HHS Watchdog Says
- Coronavirus Regulations: A State-By-State Week In Review
- Mass. Pot Regulator Again Eases Restrictions On Vapes
- States Defend FDA's Abortion Pill Restrictions At 4th Circ.
- Aceto Shareholders Lose Last Shot At Lawsuit
- How Biologics Cos. Disparage Biosimilars And How To Stop It
- VC Funding For Pharma Declines After Patent Rule Changes
- Courts Are Right To Scrutinize Food Labeling Suits
- Restrictive Covenants In California After Ixchel Pharma
- Bayer Says Essure Settlement Deal In The Works
- 3 Firms Steer Pair Of Blank Check IPOs Raising $439M
- Mylan Fights To Invalidate Novartis Blood Transfusion IP
- What Firms Should Ask Before Hiring Attorneys From Gov't
- How Federal Patent Tutorial Video Influences Jurors
- 3 Developments As Trump Orders Lasting Telehealth Changes
- Sandoz Warns Fed. Circ. Enbrel Ruling Invites Patent Abuse
- Fed. Circ. Trims Bio-Rad IP Win, But $24M Verdict Stays
- No Evidence FDA Sabotaged $375K-A-Year Drug, Judge Says
- Fed. Circ. Stays Uniloc Case For Justices' Arthrex Ruling
- Calif. High Court Establishes Tougher Antitrust Pleading Rules
- Ex-Theranos CEO Wants Too Much Info, Prosecutors Say
- 4th Circ. Backs CBS In Pharmacist's Opioid Defamation Suit
- Top Product Liability Cases Of 2020: Midyear Review
- Latham Edges Peers In Blistering July For IPOs
- Full Fed. Circ. Won't Revisit Save Of Illumina DNA Patents
- Alsup Nixes Ex-MLB Pitcher's Suit, Hints At Sanctions
- Md. Lab Says Ex-Partners Held Virus Test Results Hostage
- The Top In-House Hires Of July
- The Ethics Of Using Chatbots For Legal Services
- FDA Approves CBD Drug For Seizures Linked To Rare Disease
- Latham, Wachtell Steer Varian's $16.4B Sale To Siemens Unit